LOVFF
Cannara Biotech Inc.
Set alert
1.43 USD 0.00 0.00%
1.41 Day range 1.41
1.12 52-week range 1.55
- YTD
- +12.44%
- 1 year
- +19.00%
- Open
- 1.41
- Prev close
- 1.43
- Mkt cap
- 141.06M
- Vol
- 100
- Avg vol
- 4.84K
- EPS
- 0.08
- P/E
- 17.85
More statistics
- Low
- 1.41
- High
- 1.41
Financial health
Altman Z-Score
4.07 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A4 / 5 overall
- DCF 5
- Return on Equity 4
- Return on Assets 5
- Debt / Equity 2
- P/E 3
- P/B 4
Valuation
P/E 12.6×
FY 2018 5y median 12.6× FY 2025
P/S 1.5×
FY 2018 5y median 1.6× FY 2025
P/B 1.6×
FY 2018 5y median 1.6× FY 2025
P/FCF 11.9×
FY 2018 5y median -3.8× FY 2025
EV/EBITDA 6.7×
FY 2018 5y median 8.3× FY 2025
EV/Sales 1.8×
FY 2018 5y median 2.3× FY 2025
FCF Yield 8.4%
FY 2018 5y median -4.4% FY 2025
Profitability
Gross Margin 44.0%
FY 2018 5y median 47.6% FY 2025
Operating Margin 20.7%
FY 2018 5y median 13.8% FY 2025
Net Margin 12.2%
FY 2018 5y median 7.9% FY 2025
ROE 12.8%
FY 2018 5y median 7.3% FY 2025
ROIC 10.9%
FY 2018 5y median 7.3% FY 2025
ROA 7.8%
FY 2018 5y median 4.2% FY 2025
Growth (YoY)
Revenue 31.3%
FY 2018 FY 2025
Operating Income 120.2%
FY 2018 FY 2025
EPS (diluted) 99.1%
FY 2018 FY 2025
Free Cash Flow 324.9%
FY 2018 FY 2025
Financial Health
Current Ratio 2.4×
FY 2018 5y median 2.5× FY 2025
Quick Ratio 1.1×
FY 2018 5y median 1.1× FY 2025
Debt / Equity 0.4×
FY 2018 5y median 0.5× FY 2025
Net Debt / EBITDA 1.0×
FY 2018 5y median 2.8× FY 2025
Interest Coverage 5.9×
FY 2018 5y median 2.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-08-31